Variability in the reporting of dermatologic adverse reactions (dADRs) to EGFR inhibitors cetuximab (C) and panitumumab (P) in the treatment of metastatic colorectal cancer (mCRC)
Year: 2008
Type: conference-abstract
Source: Journal of Clinical Oncology
Language: English
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2244161667